Heron Therapeutics reported $-63888000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Alnylam Pharmaceuticals ALNY:US $ -239.36M 20.95M
Amarin AMRN:US $ -28.35M 44.74M
Anika Therapeutics ANIK:US $ -3.71M 5.46M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Eisai 4523:JP Y -20779M 34669M
Esperion Therapeutics ESPR:US $ -56731000 8.39M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Immunogen IMGN:US $ -24.14M 13.03M
Insmed INSM:US $ -94236000 18.78M
JAZZ PHA JAZZ:US $ 321.29M 19.04M
Merk MRK:US $ 6309M 1525M
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Neurocrine Biosciences NBIX:US $ 21.4M 35.2M
Omeros OMER:US $ -39494000 7.82M
Pacira Pharmaceuticals PCRX:US $ 39.79M 19.7M
Regeneron Pharmaceuticals REGN:US $ 1119.1M 1986M
Sangamo Biosciences SGMO:US $ -43.92M 6.36M
Teva Pharmaceutical Industries TEVA:US $ 766M 253M
Ultragenyx Pharmaceutical RARE:US $ -151.76M 29.32M
Veracyte VCYT:US $ -14.46M 3.15M